Guardian Pharmacy Services Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Guardian Pharmacy Services, Inc. (GRDN) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Operating Activities
Net Income-87.2923.9035.4216.3119.94
Depreciation & Amortization19.7718.2316.5616.5317.26
Stock Based Compensation131.49-6.09-3.3813.033.21
Change in Working Capital-29.4115.60-18.72-1.47-1.09
Change in Accounts Receivable-25.49-14.30-16.79-7.713.17
Change in Inventory-1.154.43-8.12-0.240.38
Change in Accounts Payable13.236.3013.379.78-1.95
Change in Other Working Capital-16.000.28-7.17-3.30-2.70
Other Operating Activities17.020.2814.5011.8810.63
Net Cash from Operating Activities57.9670.8248.5258.5052.61
Investing Activities
Capital Expenditures-16.37-14.56-16.77-9.28-8.34
Acquisitions-14.71-0.99-2.00-4.40-4.38
Other Investing Activities0.672.100.870.540.55
Net Cash from Investing Activities-30.41-13.44-17.90-13.15-12.18
Financing Activities
Debt Repayment-240.78-272.39-255.80-17.10-100.37
Common Stock Issued119.780.000.000.000.00
Common Stock Repurchased-55.180.000.000.000.00
Dividends Paid-35.75-38.42-30.80-17.36-10.82
Other Financing Activities-71.20-15.92-11.42-13.34-10.07
Net Cash from Financing Activities-23.65-57.23-45.03-36.79-34.26
Summary
Net Change in Cash3.910.15-14.418.566.17
Cash at Beginning of Period0.750.6115.016.450.00
Cash at End of Period4.660.750.6115.010.00
Free Cash Flow41.5956.2631.7549.2244.27
Supplemental Disclosures
Interest Paid3.122.781.780.002.08